Schedule 13D ownership disclosure

DOGWOOD THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 92829J203

Event date: 2026-10-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sealbond LimitedReported CIK 0002040446

    Shares: 25,920,693.00 · Class: 67.8%

  • CK Life Sciences Int'l., (Holdings) Inc.

    Shares: 28,763,331.00 · Class: 75.2%

  • Conjoint Inc.

    Shares: 2,842,638.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-119153
Form type
SCHEDULE 13D/A
Filer
Sealbond Ltd
CIK
CIK 2040446
Filed
Oct 27, 2026
Reporting period
Oct 26, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub